Indications |
Oral Alcohol withdrawal syndrome Adult: 15-30 mg 3 or 4 times daily. Elderly: or debilitated patients: Initially, 10 mg tid; increase up to 10-20 mg 3 or 4 times daily as necessary. Oral Anxiety Adult: 15-30 mg 3 or 4 times daily. Elderly: or debilitated patients: Initially, 10 mg tid; increase up to 10-20 mg 3 or 4 times daily as necessary. Oral Insomnia associated with anxiety Adult: 15-25 mg given 1 hr before bedtime. Up to 50 mg may be occasionally required. |
Contraindications |
Not for the treatment of psychoses. Pregnancy and lactation. |
Warnings / Precautions |
Cross-sensitivity with other benzodiazepines may occur. Hepatic and renal impairment. Respiratory disease. Debilitated patients, elderly, patients at risk of falls. Withdraw gradually. Porphyria; impaired gag reflex. History of drug abuse or acute alcoholism. May impair ability to drive or operate machinery. CV or cerebrovascular disease, intolerance to transient decreases in BP. Depression or if suicidal risk is present. |
Adverse Reactions |
Syncope (rare), oedema; drowsiness, ataxia, dizziness, vertigo, memory impairment, headache, paradoxical reactions (excitement, stimulation of effect), lethargy, amnesia, euphoria; rash; decreased libido, menstrual irregularities; incontinence; leukopenia, blood dyscrasias; jaundice; dysarthria, tremor, reflex slowing; blurred vision, diplopia; drug dependence. |
Overdose Reactions |
Symptoms: Somnolence, confusion, coma, hypoactive reflexes, dyspnoea, hypotension, slurred speech, impaired coordination. Treatment: Supportive. |
Drug Interactions |
Reduced sedative effects with theophylline and other CNS stimulants. Increased incidence of headache with zidovudine. May reduce effects of levodopa. Potentially Fatal: Additive CNS depression with alcohol and other CNS depressants. See Below for More oxazepam Drug Interactions |
Food Interactions |
Additive CNS depression may occur with valerian, St John's wort, kava kava, gotu kola. |
Mechanism of Actions |
Oxazepam is a short-acting benzodiazepine. It enhances the activity of GABA, a major inhibitory neurotransmitter in the brain, by binding to specific sites in the GABA receptors. Absorption: Well absorbed from the GI tract; peak plasma levels in about 2 hr (oral). Distribution: Crosses the placenta and detected in breast milk. Protein-binding: 85-97%. Metabolism: Hepatic; extensively metabolised to inactive glucuronide. Excretion: Via urine as unchanged drug and inactive metabolites. Elimination half-life: 3-21 hr. |
Administration |
May be taken with or without food. |
Storage Conditions |
Oral: Store at 15-30°C (59-86°F). |
ATC Classification |
N05BA04 - oxazepam ; Belongs to the class of benzodiazepine derivatives anxiolytics. Used in the management of anxiety, agitation or tension. |
Storage |
Oral: Store at 15-30°C (59-86°F). |
Available As |
|
Oxazepam
Post Review about Oxazepam Click here to cancel reply.
Oxazepam Containing Brands
Oxazepam is used in following diseases
Drug - Drug Interactions of Oxazepam
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.